Mediclin AG
XBER:MED
Mediclin AG
XBER:MED
Price:
3.56
EUR
Market Closed
Market Cap:
€261.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mediclin AG
XBER:MED
|
DE |
Balance Sheet
Balance Sheet Decomposition
Mediclin AG
Mediclin AG
Balance Sheet Decomposition is not available for
Mediclin AG
Mediclin AG
Balance Sheet
Mediclin AG
Mediclin AG
Currency: EUR
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
26
|
23
|
18
|
27
|
29
|
21
|
57
|
59
|
48
|
41
|
23
|
13
|
26
|
30
|
42
|
27
|
34
|
37
|
100
|
120
|
88
|
115
|
108
|
72
|
|
| Cash Equivalents |
26
|
23
|
18
|
27
|
29
|
21
|
57
|
59
|
48
|
41
|
23
|
13
|
26
|
30
|
42
|
27
|
34
|
37
|
100
|
120
|
88
|
115
|
108
|
72
|
|
| Short-Term Investments |
21
|
5
|
0
|
0
|
0
|
0
|
5
|
3
|
4
|
6
|
4
|
4
|
3
|
3
|
4
|
6
|
5
|
9
|
5
|
28
|
48
|
59
|
65
|
75
|
|
| Total Receivables |
50
|
65
|
67
|
52
|
51
|
56
|
64
|
58
|
66
|
61
|
62
|
64
|
65
|
72
|
75
|
88
|
101
|
110
|
88
|
98
|
102
|
94
|
114
|
102
|
|
| Accounts Receivables |
48
|
37
|
39
|
49
|
47
|
53
|
54
|
56
|
62
|
58
|
60
|
61
|
62
|
67
|
71
|
84
|
93
|
101
|
76
|
81
|
88
|
82
|
100
|
81
|
|
| Other Receivables |
2
|
28
|
28
|
3
|
4
|
3
|
10
|
2
|
4
|
3
|
2
|
3
|
3
|
5
|
3
|
4
|
8
|
9
|
11
|
16
|
13
|
13
|
15
|
21
|
|
| Inventory |
10
|
11
|
12
|
5
|
5
|
5
|
6
|
7
|
7
|
7
|
7
|
7
|
6
|
6
|
6
|
7
|
7
|
8
|
9
|
9
|
9
|
7
|
8
|
10
|
|
| Other Current Assets |
7
|
6
|
6
|
3
|
5
|
7
|
2
|
2
|
2
|
2
|
1
|
4
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
12
|
15
|
24
|
3
|
25
|
|
| Total Current Assets |
114
|
110
|
104
|
87
|
89
|
89
|
135
|
129
|
126
|
116
|
97
|
92
|
103
|
112
|
128
|
129
|
149
|
166
|
204
|
266
|
262
|
300
|
298
|
284
|
|
| PP&E Net |
217
|
211
|
204
|
121
|
121
|
129
|
146
|
147
|
150
|
155
|
162
|
159
|
156
|
161
|
162
|
178
|
195
|
617
|
572
|
508
|
544
|
514
|
533
|
503
|
|
| PP&E Gross |
217
|
211
|
204
|
121
|
121
|
129
|
146
|
147
|
150
|
155
|
162
|
159
|
156
|
161
|
162
|
178
|
195
|
617
|
572
|
508
|
544
|
514
|
533
|
503
|
|
| Accumulated Depreciation |
214
|
170
|
181
|
112
|
118
|
121
|
195
|
204
|
215
|
228
|
242
|
256
|
268
|
283
|
293
|
309
|
318
|
377
|
432
|
479
|
539
|
561
|
603
|
612
|
|
| Intangible Assets |
2
|
2
|
2
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
4
|
6
|
8
|
9
|
9
|
7
|
6
|
6
|
8
|
8
|
|
| Goodwill |
61
|
55
|
51
|
47
|
45
|
45
|
53
|
49
|
51
|
50
|
49
|
49
|
49
|
48
|
49
|
49
|
49
|
49
|
49
|
50
|
50
|
17
|
16
|
9
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
2
|
13
|
11
|
5
|
7
|
7
|
7
|
6
|
7
|
9
|
5
|
5
|
5
|
7
|
45
|
56
|
53
|
50
|
55
|
43
|
50
|
37
|
|
| Other Assets |
61
|
55
|
51
|
47
|
45
|
45
|
53
|
49
|
51
|
50
|
49
|
49
|
49
|
48
|
49
|
49
|
49
|
49
|
49
|
50
|
50
|
17
|
16
|
9
|
|
| Total Assets |
395
N/A
|
379
-4%
|
361
-5%
|
269
-26%
|
268
0%
|
270
+1%
|
343
+27%
|
334
-3%
|
336
+1%
|
329
-2%
|
320
-3%
|
313
-2%
|
316
+1%
|
329
+4%
|
347
+5%
|
369
+6%
|
445
+21%
|
898
+102%
|
887
-1%
|
881
-1%
|
916
+4%
|
881
-4%
|
906
+3%
|
841
-7%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
10
|
9
|
11
|
11
|
12
|
12
|
15
|
15
|
15
|
15
|
21
|
21
|
13
|
12
|
13
|
14
|
17
|
18
|
11
|
13
|
14
|
13
|
13
|
15
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
13
|
13
|
14
|
14
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
23
|
42
|
2
|
1
|
7
|
68
|
75
|
71
|
71
|
72
|
9
|
7
|
7
|
7
|
11
|
16
|
21
|
71
|
81
|
82
|
50
|
51
|
28
|
28
|
|
| Other Current Liabilities |
40
|
63
|
46
|
49
|
36
|
32
|
21
|
20
|
20
|
9
|
7
|
9
|
33
|
38
|
36
|
35
|
50
|
57
|
79
|
119
|
106
|
108
|
125
|
126
|
|
| Total Current Liabilities |
74
|
114
|
58
|
61
|
55
|
112
|
124
|
119
|
120
|
109
|
50
|
51
|
53
|
56
|
59
|
65
|
88
|
146
|
171
|
213
|
171
|
171
|
166
|
169
|
|
| Long-Term Debt |
82
|
51
|
84
|
91
|
83
|
23
|
21
|
11
|
7
|
10
|
67
|
61
|
53
|
47
|
45
|
37
|
55
|
441
|
406
|
358
|
452
|
429
|
436
|
362
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
2
|
2
|
3
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
120
|
115
|
136
|
29
|
28
|
28
|
48
|
44
|
42
|
42
|
42
|
45
|
55
|
57
|
61
|
81
|
110
|
120
|
133
|
127
|
83
|
84
|
81
|
60
|
|
| Total Liabilities |
278
N/A
|
282
+2%
|
282
0%
|
184
-35%
|
170
-8%
|
166
-3%
|
194
+17%
|
177
-9%
|
172
-3%
|
163
-5%
|
163
0%
|
161
-1%
|
161
+0%
|
160
-1%
|
165
+3%
|
183
+11%
|
253
+38%
|
707
+179%
|
710
+1%
|
698
-2%
|
707
+1%
|
685
-3%
|
683
0%
|
592
-13%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
32
|
32
|
32
|
32
|
32
|
32
|
47
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
|
| Retained Earnings |
83
|
63
|
49
|
56
|
67
|
73
|
102
|
110
|
117
|
118
|
110
|
105
|
107
|
122
|
134
|
138
|
144
|
143
|
130
|
136
|
32
|
19
|
46
|
72
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
129
|
129
|
129
|
129
|
|
| Treasury Stock |
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
117
N/A
|
97
-17%
|
80
-18%
|
85
+6%
|
98
+16%
|
104
+6%
|
149
+43%
|
157
+6%
|
165
+5%
|
166
+0%
|
157
-5%
|
152
-3%
|
154
+1%
|
169
+10%
|
182
+7%
|
186
+2%
|
192
+3%
|
191
0%
|
177
-7%
|
183
+3%
|
209
+14%
|
196
-6%
|
223
+14%
|
249
+12%
|
|
| Total Liabilities & Equity |
395
N/A
|
379
-4%
|
361
-5%
|
269
-26%
|
268
0%
|
270
+1%
|
343
+27%
|
334
-3%
|
336
+1%
|
329
-2%
|
320
-3%
|
313
-2%
|
316
+1%
|
329
+4%
|
347
+5%
|
369
+6%
|
445
+21%
|
898
+102%
|
887
-1%
|
881
-1%
|
916
+4%
|
881
-4%
|
906
+3%
|
841
-7%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
32
|
32
|
32
|
30
|
32
|
32
|
47
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
48
|
|
Switch to:
Switch to:
See Also
Discover More
